#United States #Detroit #Breast Cancer #cancer awareness #Karmanos Cancer

Raising Awareness: Karmanos Thinks Pink

As October rolls in, organizations across the U.S., including the esteemed Barbara Ann Karmanos Cancer Institute, launch campaigns to commemorate Breast Cancer Awareness Month. This observance is essential, as breast cancer is diagnosed in approximately 30% of women with cancer yearly, making it the most prevalent cancer among females, second only to skin cancer.

Breast Cancer Statistics

Breast cancer continues to impact countless lives. In the United States, over 4 million individuals are breast cancer survivors, and the relative five-year survival rate stands at an encouraging 91%. However, the threat remains real, as women have a 1 in 8 lifetime risk of developing breast cancer. In 2025, projections indicate around 316,950 new cases of invasive breast cancer, along with an estimated 59,080 new cases of ductal carcinoma in situ. Alarmingly, breast cancer persists as the second leading cause of cancer-related deaths in women, only surpassed by lung cancer. It's crucial to remember that men can also be affected, with about 2,800 new cases anticipated in 2025.

The Importance of Early Detection

Early detection of breast cancer is paramount for effective treatment, as cancer is most manageable during its initial stages. Unfortunately, early breast cancer often lacks noticeable symptoms, emphasizing the importance of regular screenings. Mammograms are the primary screening tool, allowing specialists to identify abnormalities. Karmanos encourages women aged 40 and older to schedule annual mammograms; however, some may need earlier or more frequent screenings based on individual risk factors.

At Karmanos facilities located in Detroit, Dearborn, and Farmington Hills, patients undergo a high-risk breast assessment before their mammogram. This evaluation aids in understanding the individual's risk profile for breast cancer, enabling specialists to provide personalized follow-up care, which may include genetic testing and more frequent imaging.

Recognizing Symptoms and Risk Factors

Early-stage breast cancer may not present symptoms, but when it does, a lump or mass is the most common indicator. Other potential symptoms include:

• - Changes in the skin appearance of the breast
• - Nipple retraction or discharge
• - Pain in the breast
• - Swelling or changes in breast size
• - Swollen lymph nodes

Several lifestyle choices, such as alcohol consumption, obesity, and inactivity, can increase the risk of breast cancer. Additionally, certain uncontrollable factors include genetics, family history, race, and age.

Comprehensive Cancer Care at Karmanos

The Karmanos Cancer Institute's Breast Cancer Multidisciplinary Team (MDT) consists of a diverse group of professionals, including oncologists, radiologists, pathologists, specialized nurse practitioners, and social workers. Dr. Hadeel Assad, a medical oncologist at Karmanos, notes, "We work closely together to customize treatment plans that focus on the patient's needs and preferences."

Newly diagnosed breast cancer patients can benefit from a unique clinic setup, where they meet their entire care team during one visit. This multidisciplinary approach ensures that healthcare professionals have already collaborated on the patient's case, allowing for detailed discussions about the treatment plan immediately.

Utilizing the latest in treatment technology, such as immunotherapy and minimally invasive surgery, Karmanos provides cutting-edge care, ensuring patient safety and comfort. Additionally, clinical trials are available for those seeking alternative options in their treatment journey.

For those interested in breast health or wishing to schedule a mammogram, Karmanos Cancer Institute offers resources and assistance via their website at karmanos.org/breasthealth or by calling 1-800-KARMANOS.

About Karmanos Cancer Institute

The Karmanos Cancer Institute, part of McLaren Health Care, stands as a leader in cancer care, research, and education, aiming to create a world free from cancer. Based in Detroit, Karmanos has been at the forefront of cancer treatment and innovation for over 75 years. Recognized as one of the top cancer centers nationally by the National Cancer Institute, Karmanos provides exceptional care and access to clinical trials.

For additional information, call 1-800-KARMANOS or visit karmanos.org. Stay updated by following Karmanos on social media platforms such as Facebook, LinkedIn, and YouTube.